Meltin Mmi

Developer of bio-signal processing and biologically inspired robotics

placeTokyo, Tokyo, Japan calendar_todayFounded 2013 groups25 employees language meltin.jp

Innovation

17 patent families (3 granted) — focus: Physics & computing, Operations & transport, Human necessities; filing pace slowing. Cited 396 times.

YearFilings
20171
20182
20195
20203
20217
20227
20238
20246

Investor mix

9 investors on record; lead investors include Globalink, Realtech Fund, Japan Medical Device Development Organization, Sumitomo Dainippon Pharma; 2 have since exited.

Investor typeCountShare
Venture capital222%
Private equity111%
Accelerator & incubator111%
Bank & private debt111%
Other / undisclosed444%
Coming soon